[(3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] 3,4-didecoxybenzoate

C54H90O4 — CID 102073645

IUPAC[(3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] 3,4-didecoxybenzoate
SMILESCCCCCCCCCCOc1ccc(C(=O)O[C@H]2CC[C@@]3(C)C(=CC[C@H]4[C@@H]5CC[C@H]([C@H](C)CCCC(C)C)[C@@]5(C)CC[C@@H]43)C2)cc1OCCCCCCCCCC
InChIInChI=1S/C54H90O4/c1-8-10-12-14-16-18-20-22-37-56-50-32-27-43(39-51(50)57-38-23-21-19-17-15-13-11-9-2)52(55)58-45-33-35-53(6)44(40-45)28-29-46-48-31-30-47(42(5)26-24-25-41(3)4)54(48,7)36-34-49(46)53/h27-28,32,39,41-42,45-49H,8-26,29-31,33-38,40H2,1-7H3/t42-,45+,46+,47-,48+,49+,53+,54-/m1/s1
InChIKeyNKMBPIHJUZPVLQ-OMNMSWPBSA-N
MW803.31 g/mol
LogP16.29
Rot. Bonds27

About [(3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] 3,4-didecoxybenzoate

[(3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] 3,4-didecoxybenzoate (PubChem CID 102073645) has the molecular formula C54H90O4 and a molecular weight of 803.31 g/mol. Its IUPAC name is [(3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] 3,4-didecoxybenzoate.

Molecular Properties

Compound Name[(3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] 3,4-didecoxybenzoate
PubChem CID102073645
Molecular FormulaC54H90O4
Molecular Weight803.31 g/mol
Exact Mass802.68
IUPAC Name[(3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] 3,4-didecoxybenzoate
SMILESCCCCCCCCCCOc1ccc(C(=O)O[C@H]2CC[C@@]3(C)C(=CC[C@H]4[C@@H]5CC[C@H]([C@H](C)CCCC(C)C)[C@@]5(C)CC[C@@H]43)C2)cc1OCCCCCCCCCC
InChIInChI=1S/C54H90O4/c1-8-10-12-14-16-18-20-22-37-56-50-32-27-43(39-51(50)57-38-23-21-19-17-15-13-11-9-2)52(55)58-45-33-35-53(6)44(40-45)28-29-46-48-31-30-47(42(5)26-24-25-41(3)4)54(48,7)36-34-49(46)53/h27-28,32,39,41-42,45-49H,8-26,29-31,33-38,40H2,1-7H3/t42-,45+,46+,47-,48+,49+,53+,54-/m1/s1
InChIKeyNKMBPIHJUZPVLQ-OMNMSWPBSA-N
XLogP16.29
TPSA44.76 Ų
H-Bond Donors
H-Bond Acceptors4
Rotatable Bonds27
Heavy Atoms58
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500803.31
LogP ≤ 516.29
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 104

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'isolated_alkene', 'substructure': 'N/A'}

Analyze [(3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] 3,4-didecoxybenzoate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of [(3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] 3,4-didecoxybenzoate?
The IUPAC name of [(3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] 3,4-didecoxybenzoate (CID 102073645) is [(3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] 3,4-didecoxybenzoate.
What is the SMILES notation for [(3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] 3,4-didecoxybenzoate?
The canonical SMILES for [(3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] 3,4-didecoxybenzoate is CCCCCCCCCCOc1ccc(C(=O)O[C@H]2CC[C@@]3(C)C(=CC[C@H]4[C@@H]5CC[C@H]([C@H](C)CCCC(C)C)[C@@]5(C)CC[C@@H]43)C2)cc1OCCCCCCCCCC.
What is the InChIKey of [(3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] 3,4-didecoxybenzoate?
The InChIKey is NKMBPIHJUZPVLQ-OMNMSWPBSA-N. The full InChI is InChI=1S/C54H90O4/c1-8-10-12-14-16-18-20-22-37-56-50-32-27-43(39-51(50)57-38-23-21-19-17-15-13-11-9-2)52(55)58-45-33-35-53(6)44(40-45)28-29-46-48-31-30-47(42(5)26-24-25-41(3)4)54(48,7)36-34-49(46)53/h27-28,32,39,41-42,45-49H,8-26,29-31,33-38,40H2,1-7H3/t42-,45+,46+,47-,48+,49+,53+,54-/m1/s1.
What are the key properties of [(3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] 3,4-didecoxybenzoate?
[(3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] 3,4-didecoxybenzoate has a molecular weight of 803.31 g/mol, XLogP of 16.29, 27 rotatable bonds, 0 hydrogen bond donors, and 4 hydrogen bond acceptors.
Where does this data come from?
All data for [(3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] 3,4-didecoxybenzoate is sourced from PubChem (CID 102073645), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).